Literature DB >> 23824417

Dehydroepiandrosterone supplementation in elderly men: a meta-analysis study of placebo-controlled trials.

Giovanni Corona1, Giulia Rastrelli, Vito A Giagulli, Annamaria Sila, Alessandra Sforza, Gianni Forti, Edoardo Mannucci, Mario Maggi.   

Abstract

CONTEXT: Age-related dehydroepiandrosterone (DHEA) deficiency has been associated with a broad range of biological abnormalities in males. OBJECT: Our objective was to meta-analyze all double-blind, placebo-controlled randomized trials (RCTs) investigating the effect of oral DHEA (DHEA supplementation) in comparison with placebo on sexual and metabolic outcomes in elderly men. DATA SOURCE: An extensive Medline Embase and Cochrane search was performed including the following words: DHEA, RCTs, and males. STUDY SELECTION: Only double-blind placebo-controlled trials performed in elderly men were included. DATA EXTRACTION: Data extraction was performed independently by 2 of the authors (A.S. and V.G.), and conflicts were resolved by the third investigator (G.C.). The quality of RCTs was assessed using the Cochrane criteria.
RESULTS: Of 220 retrieved articles, 25 were included in the study. The available RCTs enrolled 1353 elderly men, with a mean follow-up of 36 weeks. DHEA supplementation was associated with a reduction of fat mass (standardized mean difference of -0.35 [-0.65 to -0.05]; P = .02). However, the association with fat mass disappeared in a multivariate regression model after adjusting for DHEA-related metabolite increases such as total testosterone and estradiol. In contrast to what was observed for fat mass, no effect of DHEA supplementation in comparison with placebo was observed for various clinical parameters including lipid and glycemic metabolism, bone health, sexual function, and quality of life.
CONCLUSIONS: The present meta-analysis of intervention studies shows that DHEA supplementation in elderly men can induce a small but significant positive effect on body composition that is strictly dependent on DHEA conversion into its bioactive metabolites such as androgens or estrogens.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23824417     DOI: 10.1210/jc.2013-1358

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  14 in total

1.  Effects of Protein, Essential Amino Acids, B-Hydroxy B-Methylbutyrate, Creatine, Dehydroepiandrosterone and Fatty Acid Supplementation on Muscle Mass, Muscle Strength and Physical Performance in Older People Aged 60 Years and Over. A Systematic Review on the Literature.

Authors:  C Beaudart; V Rabenda; M Simmons; A Geerinck; I Araujo De Carvalho; J-Y Reginster; J Amuthavalli Thiyagarajan; O Bruyère
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

Review 2.  Dehydroepiandrosterone (DHEA): hypes and hopes.

Authors:  Krzysztof Rutkowski; Paweł Sowa; Joanna Rutkowska-Talipska; Anna Kuryliszyn-Moskal; Ryszard Rutkowski
Journal:  Drugs       Date:  2014-07       Impact factor: 9.546

Review 3.  [Anabolic and molecular interventions on muscle : Meaningful anti-aging strategy?]

Authors:  Thomas Münzer
Journal:  Z Gerontol Geriatr       Date:  2017-08-14       Impact factor: 1.281

4.  The use of nutraceuticals in male sexual and reproductive disturbances: position statement from the Italian Society of Andrology and Sexual Medicine (SIAMS).

Authors:  A E Calogero; A Aversa; S La Vignera; G Corona; A Ferlin
Journal:  J Endocrinol Invest       Date:  2017-06-06       Impact factor: 4.256

5.  Effects of short-term DHEA intake on hormonal responses in young recreationally trained athletes: modulation by gender.

Authors:  Katia Collomp; Corinne Buisson; Nicolas Gravisse; Soraya Belgherbi; Zakaria Labsy; Manh-Cuong Do; Olivier Gagey; Sophie Dufay; Nancy Vibarel-Rebot; Michel Audran
Journal:  Endocrine       Date:  2018-01-10       Impact factor: 3.633

6.  Androgen supplementation during aging: development of a physiologically appropriate protocol.

Authors:  Henryk F Urbanski; Krystina G Sorwell; Vasilios T Garyfallou; Jamie Garten; Alison Weiss; Laurie Renner; Martha Neuringer; Steven G Kohama
Journal:  Rejuvenation Res       Date:  2014-04-08       Impact factor: 4.663

Review 7.  Sarcopenic obesity: how do we treat it?

Authors:  Matthew F Bouchonville; Dennis T Villareal
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2013-10       Impact factor: 3.243

Review 8.  Prognostic Value of Dehydroepiandrosterone Sulfate for Patients With Cardiovascular Disease: A Systematic Review and Meta-Analysis.

Authors:  Ting-Ting Wu; Yuan Chen; Yun Zhou; Dilare Adi; Ying-Ying Zheng; Fen Liu; Yi-Tong Ma; Xiang Xie
Journal:  J Am Heart Assoc       Date:  2017-05-05       Impact factor: 5.501

9.  Identification of circadian clock modulators from existing drugs.

Authors:  T Katherine Tamai; Yusuke Nakane; Wataru Ota; Akane Kobayashi; Masateru Ishiguro; Naoya Kadofusa; Keisuke Ikegami; Kazuhiro Yagita; Yasufumi Shigeyoshi; Masaki Sudo; Taeko Nishiwaki-Ohkawa; Ayato Sato; Takashi Yoshimura
Journal:  EMBO Mol Med       Date:  2018-05       Impact factor: 12.137

10.  Healthy community-living older men differ from women in associations between myostatin levels and skeletal muscle mass.

Authors:  Li-Ning Peng; Wei-Ju Lee; Li-Kuo Liu; Ming-Hsien Lin; Liang-Kung Chen
Journal:  J Cachexia Sarcopenia Muscle       Date:  2018-04-13       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.